Media
Seven in ten pancreatic cancer patients taking desperate measures to cope with PERT shortages
We asked our supporters how they are dealing with medicine shortages and uncovered that seven in ten people with pancreatic cancer are taking desperate measures to cope. This leaves them less able to tolerate treatment, with poorer quality of life and at risk of starvation.
Cardiff scientists to discover how pancreatic cancer develops in its early stages
We have awarded almost £100,000 to researchers at Cardiff University to study how changes in a gene called ‘KRAS’ helps the deadliest common cancer develop.
Trial underway in the UK to test a new pancreatic cancer vaccine
A clinical trial of a new vaccine which aims to prevent pancreatic cancer returning after surgery is now underway in Birmingham.
New documentary about Sven-Göran Eriksson
Former manager of the England Men's football team, Sven-Göran Eriksson talks about his pancreatic cancer diagnosis in a new documentary.
Birmingham scientists develop first-of-its-kind ‘ChemoPatch’ to stop pancreatic cancer returning
Researchers at the University of Birmingham have been awarded £87,000 by our organisation to develop a new device which will deliver chemotherapy directly to tissue left behind after surgery reducing the likelihood of the cancer recurring.
Gene ‘switched off’ in early stages of pancreatic cancer, allowing rapid tumour growth and spread
The findings of a research project that we part-funded from Nottingham Trent University has now been announced, with researchers discovering that pancreatic cancer is able to 'switch off' a gene which enables it to become more aggressive.
Pancreatic Cancer UK announced as 2025 TCS London Marathon official charity of the year
Pancreatic Cancer UK is the official charity of the year for the 2025 TCS London Marathon, so "take on the ultimate test to help develop the ultimate test”
50,000 people will die of pancreatic cancer without urgent action from next Government
At least 50,000 people will die of pancreatic cancer by the end of the next five-year Parliamentary term without urgent action from the next government, we have warned, as our new ‘Demand Survival Now’ campaign launches.
Thousands of people with pancreatic cancer could live longer if shockingly low treatment rates are reversed
Almost 5,000 people with pancreatic cancer could live longer, if shockingly low treatment rates were tackled through an improved care pathway, according to our new analysis. Currently 7 in 10 patients receive no treatment at all – not even chemotherapy.
Ground-breaking research into new treatment for pancreatic cancer underway in Scotland
Pioneering research into a new potentially ground-breaking treatment for pancreatic cancer has begun. The research, lead by University of Glasgow scientist Dr Seth Coffelt, aims to help make desperately needed new immunotherapy treatments a reality for future patients.
Cambridge researchers to improve treatment options for deadliest common cancer by understanding how it grows
Researchers at the University of Cambridge will use a new cutting-edge laboratory technique to study which proteins cause uncontrolled cell-growth in pancreatic cancer and enable the devastating disease to spread rapidly.
Over 80% of GPs fear NHS winter pressures will prevent lifesaving cancer treatment
More than 8 in 10 GPs fear that extreme pressures on the NHS this winter will prevent people with pancreatic cancer and other less survivable cancers from having lifesaving treatment, according to our latest poll.